[{"orgOrder":0,"company":"Kane Biotech","sponsor":"Best Buy Medical Canada","pharmaFlowCategory":"D","therapeuticArea":"Podiatry","country":"CANADA","productType":"Other Small Molecule","year":"2025","type":"Agreement","leadProduct":"Polyhexanide","moa":"||Undisclosed","graph1":"Podiatry","graph2":"Approved FDF","graph3":"Kane Biotech","amount2":0,"highestDevelopmentShortName":"","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"Topical Gel","sponsorNew":"Kane Biotech \/ Best Buy Medical Canada","highestDevelopmentStatusID":"15","companyTruncated":"Kane Biotech \/ Best Buy Medical Canada"}]

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Bio-Europe Spring
                          Not Confirmed
                          Bio-Europe Spring
                          Not Confirmed

                          Details : The agreement aims for the distribution of revyve, an antimicrobial wound gel product line in infection management and wound healing.

                          Product Name : Revyve

                          Product Type : Other Small Molecule

                          Upfront Cash : Undisclosed

                          March 11, 2025

                          Lead Product(s) : Polyhexanide,Edetate Calcium Disodium,Citric Acid

                          Therapeutic Area : Podiatry

                          Highest Development Status : Approved FDF

                          Sponsor : Best Buy Medical Canada

                          Deal Size : Undisclosed

                          Deal Type : Agreement

                          blank